What is the recommended bedside labeling procedure to prevent mislabeling, and what information must be included?

What is the recommended bedside labeling procedure to prevent mislabeling, and what information must be included?

• A. Label at the bedside with two identifiers; include patient name, date of birth or MRN, collection date/time, tests ordered, and phlebotomist initials
• B. Label in the lab using only patient ID
• C. Use the requisition label from the nurse and place on the tube; include time
• D. Label after transport when testing begins and include only patient name

Answer: (A)

Ensuring correct patient identification and proper labeling at the point of collection is essential to prevent mislabeling. The best practice is to label the specimen at the bedside using two identifiers, then include key details on the label: the patient's name and a second identifier such as date of birth or medical record number, the collection date and time, the tests ordered, and the phlebotomist’s initials. This combination creates a secure link between the patient, the sample, and the test request, and it provides a traceable record of who collected the specimen and when. Two identifiers reduce the risk of confusing patients with similar names and provide a cross-check against the medical record. Recording the collection date and time ensures the sample is handled within its validity window and helps with timing-dependent tests. Listing the tests ordered on the label prevents misrouting or processing the wrong tests for that specimen. Phlebotomist initials establish accountability and allow follow-up if any issues arise. Other labeling approaches fall short because they lack one or more of these safeguards. Labeling in the lab with only a patient ID misses bedside verification and the necessary contextual details. Using a requisition label from a nurse on the tube can create mismatch risks if the patient information doesn’t perfectly align or if timing and test details aren’t captured on the label. Labeling after transport or including only a name omits critical identifiers and test information needed for accurate processing.

Ensuring correct patient identification and proper labeling at the point of collection is essential to prevent mislabeling. The best practice is to label the specimen at the bedside using two identifiers, then include key details on the label: the patient's name and a second identifier such as date of birth or medical record number, the collection date and time, the tests ordered, and the phlebotomist’s initials. This combination creates a secure link between the patient, the sample, and the test request, and it provides a traceable record of who collected the specimen and when.

Two identifiers reduce the risk of confusing patients with similar names and provide a cross-check against the medical record. Recording the collection date and time ensures the sample is handled within its validity window and helps with timing-dependent tests. Listing the tests ordered on the label prevents misrouting or processing the wrong tests for that specimen. Phlebotomist initials establish accountability and allow follow-up if any issues arise.

Other labeling approaches fall short because they lack one or more of these safeguards. Labeling in the lab with only a patient ID misses bedside verification and the necessary contextual details. Using a requisition label from a nurse on the tube can create mismatch risks if the patient information doesn’t perfectly align or if timing and test details aren’t captured on the label. Labeling after transport or including only a name omits critical identifiers and test information needed for accurate processing.